Seoul National University Hospital:企業の戦略的SWOT分析

◆英語タイトル:Seoul National University Hospital - Strategic SWOT Analysis Review
◆商品コード:DATA904C7688
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:政府系・NPO
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Seoul National University Hospital – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Seoul National University Hospital (SNUH) is a healthcare service provider. It operates as the representative medical center of Korea. The hospital focuses on raising the standards of nation’s healthcare system, medical education, research and patient care. It offers services such as outpatient, inpatient, medical examination, billing and insurance, issuance service, emergency service and home care services. SNUH through its Department of Education and Research provides educational and training services for professors, specialists, residents, students and staff; and through its SNU Biomedical Research Institute carries out clinical research activities. The hospital’s International Healthcare Center provides medical services for international patients and offers services such as primary medical care, medical examination, follow-up of chronic adult disease, visa medical examination, cancer screening, and aviation medicine consultation services, among others. The hospital operates through its branches including Children’s Hospital, Cancer Hospital, Healthcare System Gangnam Center, Bundang Hospital, and Boramae Hospital. SNUH is headquartered in Seoul, South Korea.

Seoul National University Hospital Key Recent Developments

Jul 24,2018: Seoul National University Hospital to Launch Syapse Precision Medicine Platform, in Cooperation with Megazone Corporation, for the First Time in the APAC Region
Jul 11,2018: SNUBH team finds new illness causing repeated dizziness
Jan 30,2018: Syapse Expands Precision Medicine to Asia through Partnerships with Seoul National University Hospital and Megazone
Nov 04,2017: Methotrexate drug holiday improves flu vaccine efficacy in rheumatoid arthritis patients
Sep 10,2017: Domestic artificial self-expandable pulmonary valve with minimized immune rejection to complete a clinical trial and ready to make headway into the overseas market

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
Section 1 – About the Company 5
Seoul National University Hospital – Key Facts 5
Seoul National University Hospital – Key Employees 6
Seoul National University Hospital – Major Products and Services 7
Seoul National University Hospital – History 8
Seoul National University Hospital – Company Statement 9
Seoul National University Hospital – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Seoul National University Hospital – Business Description 12
Seoul National University Hospital – SWOT Analysis 14
SWOT Analysis – Overview 14
Seoul National University Hospital – Strengths 14
Seoul National University Hospital – Weaknesses 15
Seoul National University Hospital – Opportunities 16
Seoul National University Hospital – Threats 17
Seoul National University Hospital – Key Competitors 18
Seoul National University Hospital, Recent Deals Summary 19
Section 3 – Company’s Recent Developments 20
Jul 24, 2018: Seoul National University Hospital to Launch Syapse Precision Medicine Platform, in Cooperation with Megazone Corporation, for the First Time in the APAC Region 20
Jan 30, 2018: Syapse Expands Precision Medicine to Asia through Partnerships with Seoul National University Hospital and Megazone 21
Nov 04, 2017: Methotrexate drug holiday improves flu vaccine efficacy in rheumatoid arthritis patients 22
Sep 10, 2017: Domestic artificial self-expandable pulmonary valve with minimized immune rejection to complete a clinical trial and ready to make headway into the overseas market 23
Section 4 – Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Seoul National University Hospital, Key Facts 5
Seoul National University Hospital, Key Employees 6
Seoul National University Hospital, Major Products and Services 7
Seoul National University Hospital, History 8
Seoul National University Hospital, Other Locations 10
Seoul National University Hospital, Subsidiaries 10
Seoul National University Hospital, Key Competitors 18
Seoul National University Hospital, Recent Deals Summary 19

★海外企業調査レポート[Seoul National University Hospital:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sino Biopharmaceutical Ltd (1177):企業の財務・戦略的SWOT分析
    Sino Biopharmaceutical Ltd (1177) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Thermo Fisher Scientific Inc (TMO):企業の財務・戦略的SWOT分析
    Thermo Fisher Scientific Inc (TMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • InspireMD Inc (NSPR):企業の財務・戦略的SWOT分析
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Marriott International Inc:企業の戦略・SWOT・財務情報
    Marriott International Inc - Strategy, SWOT and Corporate Finance Report Summary Marriott International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Immuron Ltd (IMC):企業の財務・戦略的SWOT分析
    Summary Immuron Ltd (Immuron), formerly Anadis Ltd is a biopharmaceutical company that develops oral immunotherapy therapeutics using polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. It pro …
  • Rabigh Refining & Petrochemical Co (2380):企業の財務・戦略的SWOT分析
    Rabigh Refining & Petrochemical Co (2380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Graphic Packaging Holding Company:企業の戦略・SWOT・財務情報
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • China Pharma Holdings Inc (CPHI):企業の財務・戦略的SWOT分析
    China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • APEIRON Biologics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary APEIRON Biologics AG (APEIRON) is a clinical-stage biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers. The company’s pipeline products include APN01, APN301, APN311, APN401, APN411, APN421 and APN431. Its …
  • PT Bayan Resources Tbk.:企業の戦略・SWOT・財務情報
    PT Bayan Resources Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT Bayan Resources Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nine Entertainment Co. Holdings Ltd:企業の戦略・SWOT・財務分析
    Nine Entertainment Co. Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Entertainment Co. Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • The Charles Schwab Corporation:企業のM&A・事業提携・投資動向
    The Charles Schwab Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Charles Schwab Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Known as Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary p …
  • Chemo Espana SA-製薬・医療分野:企業M&A・提携分析
    Summary Chemo Espana SA (Chemo Group) is a pharmaceutical company, which conducts research, development, manufacture, sales and marketing of active pharmaceutical ingredients (APIs), finished dosage forms and branded pharmaceuticals. Its product portfolio includes steroids, hormones and antibiotics …
  • Petrolina (Holdings) Public Ltd (PHL):企業の財務・戦略的SWOT分析
    Petrolina (Holdings) Public Ltd (PHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Dragon Oil Plc:企業の戦略的SWOT分析
    Dragon Oil Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Digital China Holdings Limited:企業の戦略・SWOT・財務分析
    Digital China Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Digital China Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Revance Therapeutics Inc (RVNC):医療機器:M&Aディール及び事業提携情報
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆